- Home
- ANIX vs NIM Comparison
ANIX vs NIM Comparison
Compare ANIX & NIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- NIM
- Stock Information
- Founded
- ANIX 1982
- NIM 1992
- Country
- ANIX United States
- NIM United States
- Employees
- ANIX N/A
- NIM N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- NIM Trusts Except Educational Religious and Charitable
- Sector
- ANIX Health Care
- NIM Finance
- Exchange
- ANIX Nasdaq
- NIM Nasdaq
- Market Cap
- ANIX 108.9M
- NIM 113.7M
- IPO Year
- ANIX 1987
- NIM N/A
- Fundamental
- Price
- ANIX $3.18
- NIM $9.10
- Analyst Decision
- ANIX Strong Buy
- NIM
- Analyst Count
- ANIX 3
- NIM 0
- Target Price
- ANIX $9.00
- NIM N/A
- AVG Volume (30 Days)
- ANIX 104.7K
- NIM 35.4K
- Earning Date
- ANIX 09-05-2025
- NIM 01-01-0001
- Dividend Yield
- ANIX N/A
- NIM 3.46%
- EPS Growth
- ANIX N/A
- NIM N/A
- EPS
- ANIX N/A
- NIM N/A
- Revenue
- ANIX N/A
- NIM N/A
- Revenue This Year
- ANIX N/A
- NIM N/A
- Revenue Next Year
- ANIX N/A
- NIM N/A
- P/E Ratio
- ANIX N/A
- NIM N/A
- Revenue Growth
- ANIX N/A
- NIM N/A
- 52 Week Low
- ANIX $2.07
- NIM $8.28
- 52 Week High
- ANIX $4.20
- NIM $9.74
- Technical
- Relative Strength Index (RSI)
- ANIX 42.92
- NIM 53.24
- Support Level
- ANIX $3.21
- NIM $8.97
- Resistance Level
- ANIX $3.24
- NIM $9.13
- Average True Range (ATR)
- ANIX 0.15
- NIM 0.08
- MACD
- ANIX -0.02
- NIM 0.00
- Stochastic Oscillator
- ANIX 6.98
- NIM 67.84
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About NIM Nuveen Select Maturities Municipal Fund
Nuveen Select Maturities Municipal Fund is a diversified closed-end management investment company. Its primary investment objective is to provide current income exempt from regular federal income tax, consistent with the preservation of capital. Its secondary investment objective is to enhance portfolio value relative to the municipal bond market through investments in tax-exempt municipal obligations that are underrated or undervalued, or that represent municipal market sectors that are undervalued.